secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001193125-23-039399
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio reports estimated cash and securities of $108M as of Dec 31, 2022
-----------------------------------------------------------------------------

- Preliminary estimate of cash, cash equivalents and marketable securities as of Dec 31, 2022: approximately $108.0M.
- Includes $104.6M cash & equivalents and $3.4M marketable securities.
- These are preliminary estimates; final results may differ and will be in Form 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000119312523039399/0001193125-23-039399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000119312523039399/d403722d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-039399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer